Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases.

作者: M. Wagner , E. R. Suarez , T. R. Theodoro , C. D. A. S. Machado Filho , M. F. M. Gama

DOI: 10.1111/J.1365-2230.2011.04291.X

关键词: Proliferating cell nuclear antigenPhotodynamic therapyDownregulation and upregulationExperimental pathologyMelanomaBiologyHeparanaseMolecular biologyReactive oxygen speciesImmunohistochemistry

摘要: Summary Background.  Malignant melanoma (MM) is a very aggressive tumour. Although surgical excision of MM in the early stages has good prognosis, it often fails to completely inhibit tumour progression. Methylene blue photodynamic therapy (MB-PDT) technique that induces tissue damage by reactive oxygen species (ROS). Aim.  To investigate efficacy and potential use MB-PDT restraining aggressiveness analysing levels proliferating cell nuclear antigen (PCNA) heparanase (HPSE, molecular marker invasion) mouse model. Methods.  Expression PCNA two HPSE isoforms were analysed using immunohistochemistry (IHC) after mice. Tumour volume weight also measured. Results.  Two treatments with promoted decrease 99% 75% compared untreated mice (P < 0.05). Using IHC, expression for 95% both (P < 0.05) was found. Conclusion.  cheap efficient method decreasing thus disease This reduction mediated downregulation heparanases.

参考文章(21)
E. Baker, J. Crawford, G.R. Sutherland, C. Freeman, C.R. Parish, M.D. Hulett, Human HPA endoglycosidase heparanase. Map position 4q21.3. Chromosome Research. ,vol. 7, pp. 319- 319 ,(1999) , 10.1023/A:1009235132576
Eva M. Link, Robert N. Carpenter, Joseph S. Mitchell, Ian Brown, Uptake and Therapeutic Effectiveness of 125I- and 211At-Methylene Blue for Pigmented Melanoma in an Animal Model System Cancer Research. ,vol. 49, pp. 4332- 4337 ,(1989)
João Paulo Tardivo, Auro Del Giglio, Carla Santos de Oliveira, Dino Santesso Gabrielli, Helena Couto Junqueira, Dayane Batista Tada, Divinomar Severino, Rozane de Fátima Turchiello, Mauricio S. Baptista, Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications. Photodiagnosis and Photodynamic Therapy. ,vol. 2, pp. 175- 191 ,(2005) , 10.1016/S1572-1000(05)00097-9
Jane Reiland, Doty Kempf, Madhuchhanda Roy, Yvonne Denkins, Dario Marchetti, FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells. Neoplasia. ,vol. 8, pp. 596- 606 ,(2006) , 10.1593/NEO.06244
Edward McKenzie, Kerry Tyson, Alasdair Stamps, Paul Smith, Paul Turner, Richard Barry, Margaret Hircock, Sonal Patel, Eleanor Barry, Colin Stubberfield, Jon Terrett, Martin Page, Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochemical and Biophysical Research Communications. ,vol. 276, pp. 1170- 1177 ,(2000) , 10.1006/BBRC.2000.3586
Sonal Choudhary, Keyvan Nouri, Mohamed L Elsaie, None, Photodynamic therapy in dermatology: a review Lasers in Medical Science. ,vol. 24, pp. 971- 980 ,(2009) , 10.1007/S10103-009-0716-X
ORIT GOLDSHMIDT, EYAL ZCHARIA, MIRIAM COHEN, HELENA AINGORN, IRIT COHEN, LIAT NADAV, BEN-ZION KATZ, BENJAMIN GEIGER, ISRAEL VLODAVSKY, Heparanase mediates cell adhesion independent of its enzymatic activity The FASEB Journal. ,vol. 17, pp. 1015- 1025 ,(2003) , 10.1096/FJ.02-0773COM
Rosario Rivera, Hitoshi Nagatsuka, Chong Siar, Mehmet Gunduz, Hidetsugu Tsujigiwa, Phuu Han, Naoki Katase, Ryo Tamamura, Kok Ng, Yoshio Naomoto, Motowo Nakajima, Noriyuki Nagai, Heparanase and vascular endothelial growth factor expression in the progression of oral mucosal melanoma. Oncology Reports. ,vol. 19, pp. 657- 661 ,(2008) , 10.3892/OR.19.3.657
Katrin Kalka, Hans Merk, Hasan Mukhtar, Photodynamic therapy in dermatology Journal of The American Academy of Dermatology. ,vol. 42, pp. 389- 413 ,(2000) , 10.1016/S0190-9622(00)90209-3
Barbra B. Noodt, Gry Hege Rodal, Mark Wainwright, Qian Peng, Richard Horobin, Jahn M. Nesland, Kristian Berg, Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells International Journal of Cancer. ,vol. 75, pp. 941- 948 ,(1998) , 10.1002/(SICI)1097-0215(19980316)75:6<941::AID-IJC18>3.0.CO;2-5